Engineering the (Immune) System - DistributedBio
On today’s episode, we’ll sit down with DistributedBio co-founder and CEO Jacob Glanville, and Centivax program lead and director of contract research Sarah Ives. We’ll hear more about the company's founding story, get perspective on bootstrapping a biotech company, and learn more about their internal and client development programs that cover everything from vaccines, antibodies, and chimeric antigen receptor (CAR) T cell therapies, and which target diseases as varied as influenza, HIV, cancer, and even the SARS-CoV2 Coronavirus. This is the TomorrowScale podcast, hosted by Justin Briggs.
DistributedBio (https://distributedbio.com)
Follow us on Twitter (https://twitter.com/tomorrowscale)
The TomorrowScale Podcast was created by Justin Briggs to showcase scientists and entrepreneurs who are building the future, and to hear their stories from the benches and in the trenches of research & development. The views expressed by the host and guests are their own, and the content of this show should not be considered legal, tax, or investing advice. Thanks to our guests for sharing their time and knowledge with us. Thank you for listening. Please science responsibly.
--- Support this podcast: https://podcasters.spotify.com/pod/show/tomorrowscale/support
TomorrowScale Podcast
Conversations with the scientists and entrepreneurs who are building the future. Support this podcast: https://podcasters.spotify.com/pod/show/tomorrowscale/support
- No. of episodes: 27
- Latest episode: 2021-12-03
- Science
Where can you listen?
